Average and individual sets of plasma concentration-time data for acetaminophen following two
INTRODUCTION
The utility of pharmacokinetics for quantification of drug absorption and disposition is well documented (1) . The approach permits predictions regarding drug dosage adjustment and, in addition, allows for comparison of the effects of dosage form variables on therapeutic efficacy and/or bioavailability. In a recent study, Albert et al. (2) noted differences in rates of absorption of acetaminophen when the drug was administered separately to ten healthy volunteers both as a commercial tablet and as a specially formulated soft gelatin capsule. In this report, the pharmacokinetic model which was elaborated from the plasma concentration-time data will be discussed.
EXPERIMENTAL

Treatment of Data
The study conditions were described in a previous report (2) 
Weighting Considerations
Equation 1, which describes a relationship between variance and concentration, may be used to test a feasible weighting factor (wi) for fitting individual subject plasma concentrations to a model based on the mean plasma levels of the panel of subjects to which the individuals belong:
where a 2 is the variance corresponding to mean concentration C and a and n are constants. Taking logarithms of both sides of equation 1 gives equation 2:
In a 2 = lna + nln C
Plotting In a 2 vs. In C generates a straight line with intercept In a (corresponding to C = 1) and slope n. If n = 1, w~ = 1/Ci; if n = 2, wi = 1/C~. This is a reasonable method for estimating the appropriate weights for an individual subject set of plasma level data since there is only one observation at each time. Adherence to equation 2 indicates that the trends in variance across a concentration-time curve are due only to the magnitude of the plasma concentrations and are independent of time or other effects. If the correlation coefficient is very high for the averages (i.e., for the mean plasma levels) when equation 2 is applied, then one could use w i = 1/a(C)" to fit average plasma concentrations, or one could still use the weighting factor 1/a~ (as we chose to do) where a~ is calculated from the panel's concentrations at each time t~. In using the variance of mean plasma concentrations, the sampling times have to be the same for each subject, as they were in our study.
Theoretical Treatment of Disposition Rate Parameters
The microscopic rate constants k12 , k21 , and kel which describe the disposition portion of Model I can be used to estimate how well C,t data 
RA is equal to the average amount of drug in the body during a dosage interval at the equilibrium state divided by the amount of drug absorbed following a single maintenance dose. Since RA can be estimated from the parameters of the two-compartment model, the loading dose for a multiple dosing regimen can be calculated using equation 7:
Loading dose = RA" maintenance dose (
The central compartment correction factor is of particular importance in estimating loading doses since the loading dose using the two-compartment equation (equation 6) will always be less than the loading dose estimated using the one-compartment equation (equation 4) for equal main-tenance doses. It is possible that with some drugs toxicity problems are caused by use of the inappropriate model to estimate the loading dose. Table I lists the pharmacokinetic parameters obtained by simultaneously fitting mean plasma concentrations of acetaminophen to Model I and equations A1 and A2 of the Appendix. In such simultaneous fitting, the weighted sum of squared deviations of both sets of data is minimized. With the exception of wi = 1/a~, the weighting factors had little influence on the parameter estimates and their corresponding coefficients of variation. Use of w i = 1/a~ gave different values for the parameters and higher coefficients of variation of the estimates. Table II gives the parameter estimates from simultaneous fitting of the two sets of C,t data for each subject to Model I employing the weighting factors 1/Ci and 1/C 2. Equal weighting was not used since the error in the GLC assay was concentration dependent and this error is a part of the total error. A paired t-test indicated in each case that the means of the estimates obtained using the different weighting schemes did not differ significantly. The reasonably high r 2 and Corr values indicated the applicability to the data of the two-compartment open model with first-order absorption and lag time. In addition, weighted residual plots, a typical example of which is shown in Fig. 1 , gave no evidence of trends or regions of poor fit. Figures 2  and 3 graphically compare the observed and model-predicted concentrations for subjects 4 and 9. These data represent the worst and best fits, respectively. (Although Table II shows that subject 7 gave the worst fit, the observed plasma levels indicated that it was impossible to fit these data to any linear model. Hence this subject's parameters were not included in any averages.)
RESULTS
A comparison of the disposition rate parameters in Tables I and II  reveals that aObtained by averaging columns headed "I/C~ weighting" and "l/(Ci) 2 weighting" in Table I . bObtained by averaging the row titled "Subject average" in Table II . reflects those derived from individual subject data. This is clearly shown in Table III . The observation is not surprising since the pattern of variances that occurs across an average blood level curve would be the same pattern expected if the same subject were administered the same treatment a large number of times. This suggests that equation 2 can be used to estimate the appropriate weight for individual subject sets of acetaminophen data using the mean plasma levels of the panel. Application of equation 2 gave a 2 = 0.252(C) 2'~ (r = 0.818). Therefore, weighting individual subject sets of C,t data according to 1/C~ is statistically justified in this case. Table IV lists since fl is not clearly small enough compared to k 21 (see Table II 
DISCUSSION
The simultaneous fitting of plasma concentration-time data for each subject to Model I and equations A1 and A2 of the Appendix revealed that in general k~ > kA. Absorption-time plots based on the Loo-Riegelman method (4) gave results consistent with firs-t-order input kinetics. This supports and quantifies previous observations by Albert et al. (2) , who reported that when acetaminophen was administered in the form of a commercial tablet it was more rapidly absorbed than when it was administered as a soft gelatin capsule. Evaluation of the data in Table II also showed that the apparent plasma clearance area remained constant intrasubject. Evidence for this is provided by a paired t-test in which a comparison of the means of the dose/area ratios following treatments A and B gave differences that tested not significant (t = 1.82, df = 8). This suggests that efficiencies of absorption of acetaminophen can be estimated by a direct comparison of areas under the C, t curves rather than by invoking the corrected area procedure described by Wagner (5) .
Simultaneous fitting of two or more sets of plasma data to a model is generally preferred to individual fitting since there is an appreciable increase in the degrees of freedom. The standard deviations of the estimated parameters are consequently reduced (6) . Nine parameters were estimated by simultaneous fitting of between 15 and 20 data points (depending on the magnitude oft0) rather than by use of six to ten data points for six parameters, as would be the case in individual fitting of these data. The parameters k 1 z, kzl, and kel were assumed constant intrasubject from treatment to treatment.
Therefore, only one value of each was estimated. Initial estimates of these disposition rate constants obtained by use of an electronic calculator indicated that, indeed, this constancy assumption was justified with acetaminophen.
Model I shows loss of drug from the inner compartment only. The data could have been fitted equally well to Model II with loss from the outer compartment or to Model III with loss from both compartments: Model III Since these models are pharmacokinetically indistinguishable when only the central compartment is available for sampling, only three rate parameters can be determined in the disposition portion of the model (7) even though four microscopic rate constants are pictorially depicted in Model III. If one wishes to calculate the values of k12, k2t, and kel for Model II or k12, E 2 = k2x + (kel)2, and (ket)l for Model III from the parameters estimated for Model I, the conversion equations are readily obtained. 
APPENDIX Equations Employed in Simultaneous Fitting
